New hope for aggressive brain cancer? major trial tests promising drug
Disease control
Recruiting now
This study is testing if a drug called niraparib helps adults with a newly diagnosed, aggressive brain tumor (glioblastoma) live longer than the current standard drug, temozolomide. About 450 participants will be randomly assigned to receive one of these two drugs, taken daily al…
Phase: PHASE3 • Sponsor: Ivy Brain Tumor Center • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC